Skip to content

Daily dosing key to the efficacy of tenofovir-based HIV PrEP

New booklet from NAM: Taking your HIV treatment

New booklet from NAM: Taking your HIV treatment

No significant risk of resistance if HIV infection occurs during use of Truvada PrEP

Even moderate drinking increases risk of advanced liver fibrosis for people with HIV and HCV co-infection

Annual HIV tests for high-risk groups and one-off screening for all others could have a big impact on UK's HIV epidemic

Sofosbuvir + ribavirin is safe and effective for HCV recurrence after liver transplantation

Voucher incentives improve engagement with HIV care among people who inject drugs

Sustained response to treatment reduces fatigue in hepatitis C patients

Investigational protease inhibitor TMC310911 highly potent in phase 2 study